Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

Title
Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 11, Pages 3012-3022
Publisher
American Association for Cancer Research (AACR)
Online
2014-04-02
DOI
10.1158/1078-0432.ccr-13-3006

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started